14 August 2018 - Galderma Canada is pleased to announce that Health Canada has approved Dysport Aesthetic (abobotulinumtoxinA) for the temporary improvement in the appearance of moderate to severe lateral canthal lines (crow's feet) in adult patients. 

Dysport Aesthetic is also approved for the temporary improvement in the appearance of moderate to severe glabellar lines (frown lines) in adult patients younger than 65 years of age.

The approval of Dysport Aesthetic by Health Canada is based on the results of a double-blind, randomised, placebo-controlled, Phase 3 study that involved 335 subjects.

Read Galderma press release